Monovisc Injection is a single injection viscosupplement suited for treatment of the joint pain caused by osteoarthritis. In cases of osteoarthritis, the amount of natural hyaluronan is reduced and the quality may be poorer than normal, which causes irritation and inflammation, pain and stiffness in the joints. Monovisc is a gel substance that consists of the maximum dose of HA (88mg). The product adds HA to the joint when injected, where it acts as a lubricant and pain reliever.
Monovisc is given in a shot (injection) directly into the knee joint.
The pack of Monovisc Injection consists of:
- 1 Syringe x 4ml per pack
Composition of the product:
- Partially cross-linked sodium Hyaluronate (NaHA)
- 88 mg Hyaluronan
- 36 mg Sodium Chloride
Benefits of Monovisc 4ml:
- Single injection treatment
- Immediate pain relief
How long does the result last for?
Monovisc can provide up to 6 months of pain relief. The results may vary individually, some people feel relief immediately after their injection.
Directions For Use
Monovisc is injected into the knee joint and is administered as a single intra-articular injection. Standard intra-articular injection site preparation and precautions should be used. Strict aseptic administration technique must be followed. Monoviscis a proprietary high molecular weight hyaluronic acid (HA) visco-supplementation intended for the treatment of pain in patients with moderate osteoarthritis (OA) of the knee who have failed conservative non-pharmacological therapy and simple analgesics. The device is administered by a single injection via the para-patellar approach under sterile conditions.